{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:12:54Z","timestamp":1770999174596,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1208\/s12249-017-0752-y","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T14:49:09Z","timestamp":1489416549000},"page":"2702-2705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Trans-ungual Delivery of AR-12, a Novel Antifungal Drug"],"prefix":"10.1208","volume":"18","author":[{"given":"Avadhesh Singh","family":"Kushwaha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. N.","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rappleye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zukiwski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Proniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Narasimha","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"752_CR1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CMR.11.3.415","volume":"11","author":"BE Elewski","year":"1998","unstructured":"Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev. 1998;11:415\u201329.","journal-title":"Clin Microbiol Rev"},{"key":"752_CR2","doi-asserted-by":"crossref","unstructured":"Murthy SN, Maibach H. Topical nail products and ungual drug delivery. ed. CRC Press, Taylor M & Francis; 2013.","DOI":"10.1201\/b12896"},{"key":"752_CR3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3109\/03639045.2015.1033426","volume":"41","author":"A Kushwaha","year":"2015","unstructured":"Kushwaha A, Murthy RN, Murthy SN, Elkeeb R, Hui X, Maibach HI. Emerging therapies for the treatment of ungual onychomycosis. Drug Dev Ind Pharm. 2015a;41:1575\u201381.","journal-title":"Drug Dev Ind Pharm"},{"key":"752_CR4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/03639045.2011.637931","volume":"38","author":"HN Shivakumar","year":"2012","unstructured":"Shivakumar HN, Juluri A, Desai BG, Murthy SN. Ungual and transungual drug delivery. Drug Dev Ind Pharm. 2012;38:901\u201311.","journal-title":"Drug Dev Ind Pharm"},{"key":"752_CR5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0891-8422(23)00838-8","volume":"13","author":"MM Chiritescu","year":"1996","unstructured":"Chiritescu MM, Chiritescu ME, Scher RK. Newer systemic antifungal drugs for the treatment of onychomycosis. Clin Podiatr Med Surg. 1996;13:741\u201358.","journal-title":"Clin Podiatr Med Surg"},{"key":"752_CR6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/17512433.2016.1206467","volume":"9","author":"AK Gupta","year":"2016","unstructured":"Gupta AK, Versteeg SG. Tavaborole\u2014a treatment for onychomycosis of the toenails. Expert Rev Clin Pharmacol. 2016;9:1145\u201352.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"752_CR7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3109\/03639045.2014.927481","volume":"41","author":"A Kushwaha","year":"2015","unstructured":"Kushwaha A, Jacob M, Shiva Kumar HN, Hiremath S, Aradhya S, Repka MA, Murthy SN. Trans-ungual delivery of itraconazole hydrochloride by iontophoresis. Drug Dev Ind Pharm. 2015b;41:1089\u201394.","journal-title":"Drug Dev Ind Pharm"},{"key":"752_CR8","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4161\/cbt.22275","volume":"13","author":"L Booth","year":"2012","unstructured":"Booth L, Cruickshanks N, Ridder T, Chen CS, Grant S, Dent P. OSU-03012 interacts with lapatinib to kill brain cancer cells. Cancer Biol Ther. 2012;13:1501\u201311.","journal-title":"Cancer Biol Ther"},{"key":"752_CR9","unstructured":"Proniuk S, Wiederhold NP, Patterson TF, Cushion MT, Krysan DJ, Green J, et al. 2015. AR-12, lead compound of a potential new class of antifungal agents. ed., ACAAC\/ICC."},{"key":"752_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/156720110793566308","volume":"7","author":"AB Nair","year":"2010","unstructured":"Nair AB, Chakraborty B, Murthy SN. Effect of polyethylene glycols on the trans-ungual delivery of terbinafine. Curr Drug Deliv. 2010;7:407\u201314.","journal-title":"Curr Drug Deliv"},{"key":"752_CR11","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1007\/s11095-009-9934-y","volume":"26","author":"AB Nair","year":"2009","unstructured":"Nair AB, Kim HD, Davis SP, Etheredge R, Barsness M, Friden PM, Murthy SN. An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine. Pharm Res. 2009a;26:2194\u2013201.","journal-title":"Pharm Res"},{"key":"752_CR12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","volume":"31","author":"AK Gupta","year":"2013","unstructured":"Gupta AK, Paquet M, Simpson FC. Therapies for the treatment of onychomycosis. Clin Dermatol. 2013;31:544\u201354.","journal-title":"Clin Dermatol"},{"key":"752_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","volume":"236","author":"S Murdan","year":"2002","unstructured":"Murdan S. Drug delivery to the nail following topical application. Int J Pharm. 2002;236:1\u201326.","journal-title":"Int J Pharm"},{"key":"752_CR14","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/jps.23139","volume":"101","author":"P Manda","year":"2012","unstructured":"Manda P, Sammeta SM, Repka MA, Murthy SN. Iontophoresis across the proximal nail fold to target drugs to the nail matrix. J Pharm Sci. 2012;101:2392\u20137.","journal-title":"J Pharm Sci"},{"key":"752_CR15","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1002\/jps.21743","volume":"98","author":"SN Murthy","year":"2009","unstructured":"Murthy SN, Vaka SR, Sammeta SM, Nair AB. TranScreen-N: method for rapid screening of trans-ungual drug delivery enhancers. J Pharm Sci. 2009;98:4264\u201371.","journal-title":"J Pharm Sci"},{"key":"752_CR16","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1002\/jps.21711","volume":"98","author":"AB Nair","year":"2009","unstructured":"Nair AB, Kim HD, Chakraborty B, Singh J, Zaman M, Gupta A, Friden PM, Murthy SN. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci. 2009b;98:4130\u201340.","journal-title":"J Pharm Sci"},{"key":"752_CR17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3109\/03639045.2011.568946","volume":"37","author":"AB Nair","year":"2011","unstructured":"Nair AB, Vaka SR, Murthy SN. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails. Drug Dev Ind Pharm. 2011;37:1253\u20138.","journal-title":"Drug Dev Ind Pharm"},{"key":"752_CR18","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/jps.21555","volume":"98","author":"AB Nair","year":"2009","unstructured":"Nair AB, Vaka SR, Sammeta SM, Kim HD, Friden PM, Chakraborty B, Murthy SN. Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci. 2009c;98:1788\u201396.","journal-title":"J Pharm Sci"},{"key":"752_CR19","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1002\/jps.21664","volume":"98","author":"J Hao","year":"2009","unstructured":"Hao J, Smith KA, Li SK. Iontophoretically enhanced ciclopirox delivery into and across human nail plate. J Pharm Sci. 2009;98:3608\u201316.","journal-title":"J Pharm Sci"},{"key":"752_CR20","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3109\/03639045.2016.1165690","volume":"42","author":"A Kushwaha","year":"2016","unstructured":"Kushwaha A, Shivakumar HN, Murthy SN. Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery. Drug Dev Ind Pharm. 2016;42:1678\u201382.","journal-title":"Drug Dev Ind Pharm"},{"key":"752_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1211\/0022357991772448","volume":"51","author":"Y Kobayashi","year":"1999","unstructured":"Kobayashi Y, Miyamoto M, Sugibayashi K, Morimoto Y. Drug permeation through the three layers of the human nail plate. J Pharm Pharmacol. 1999;51:271\u20138.","journal-title":"J Pharm Pharmacol"},{"key":"752_CR22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2006.12.010","volume":"46","author":"SN Murthy","year":"2007","unstructured":"Murthy SN, Waddell DC, Shivakumar HN, Balaji A, Bowers CP. Iontophoretic permselective property of human nail. J Dermatol Sci. 2007;46:150\u20132.","journal-title":"J Dermatol Sci"},{"key":"752_CR23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/10717544.2016.1256000","volume":"24","author":"GR Adelli","year":"2017","unstructured":"Adelli GR, Balguri SP, Bhagav P, Raman V, Majumdar S. Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery. Drug Deliv. 2017;24:370\u20139.","journal-title":"Drug Deliv"},{"key":"752_CR24","first-page":"463","volume":"55","author":"GR Adelli","year":"2014","unstructured":"Adelli GR, Balguri SP, Punyamurthula N, Bhagav P, Majumdar S. Development and evaluation of prolonged release topical indomethacin formulations for ocular inflammation. Invest Ophthalmol Vis Sci. 2014;55:463.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"752_CR25","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1167\/iovs.14-16288","volume":"56","author":"SP Balguri","year":"2015","unstructured":"Balguri SP, Adelli G, Bhagav P, Repka MA, Majumdar S. Development of nano structured lipid carriers of ciprofloxacin for ocular delivery: characterization, in vivo distribution and effect of PEGylation. Invest Ophthalmol Vis Sci. 2015;56:2269.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"752_CR26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2016.10.015","volume":"109","author":"SP Balguri","year":"2016","unstructured":"Balguri SP, Adelli GR, Majumdar S. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur J Pharm Biopharm. 2016;109:224\u201335.","journal-title":"Eur J Pharm Biopharm"},{"key":"752_CR27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archderm.1954.01540240038005","volume":"70","author":"BL Lewis","year":"1954","unstructured":"Lewis BL. Microscopic studies of fetal and mature nail and surrounding soft tissue. AMA Arch Derm Syphilol. 1954;70:733\u201347.","journal-title":"AMA Arch Derm Syphilol"},{"key":"752_CR28","unstructured":"Kyowa. D-Panthenol\/Dexpanthenol."},{"key":"752_CR29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1524-4725.2005.31724","volume":"31","author":"JJ Thiele","year":"2005","unstructured":"Thiele JJ, Hsieh SN, Ekanayake-Mudiyanselage S. Vitamin E: critical review of its current use in cosmetic and clinical dermatology. Dermatol Surg. 2005;31:805\u201313.","journal-title":"Dermatol Surg"},{"key":"752_CR30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejps.2013.02.006","volume":"49","author":"Y Guo","year":"2013","unstructured":"Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49:175\u201386.","journal-title":"Eur J Pharm Sci"},{"key":"752_CR31","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1002\/jps.24114","volume":"103","author":"KB Seljak","year":"2014","unstructured":"Seljak KB, Berginc K, Trontelj J, Zvonar A, Kristl A, Ga\u0161perlin M. A self-microemulsifying drug delivery system to overcome intestinal resveratrol toxicity and presystemic metabolism. J Pharm Sci. 2014;103:3491\u2013500.","journal-title":"J Pharm Sci"},{"key":"752_CR32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000107575","volume":"20","author":"H-Y Thong","year":"2007","unstructured":"Thong H-Y, Zhai H, Maibach HI. Percutaneous penetration enhancers: an overview. Skin Pharmacol Physiol. 2007;20:272\u201382.","journal-title":"Skin Pharmacol Physiol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-017-0752-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-017-0752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T23:19:06Z","timestamp":1719098346000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-017-0752-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1208\/s12249-017-0752-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}